SARRECCHIA, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 11.272
EU - Europa 1.212
AS - Asia 1.145
SA - Sud America 177
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 13.832
Nazione #
US - Stati Uniti d'America 11.236
SG - Singapore 583
CN - Cina 267
IT - Italia 183
DE - Germania 156
UA - Ucraina 148
BR - Brasile 146
RU - Federazione Russa 123
FR - Francia 121
PL - Polonia 99
SE - Svezia 97
IE - Irlanda 89
VN - Vietnam 84
FI - Finlandia 82
HK - Hong Kong 70
GB - Regno Unito 54
KR - Corea 32
JP - Giappone 29
CA - Canada 17
BD - Bangladesh 15
IN - India 15
CZ - Repubblica Ceca 13
MX - Messico 13
AR - Argentina 11
BE - Belgio 11
ID - Indonesia 8
NL - Olanda 8
TR - Turchia 8
ES - Italia 7
ZA - Sudafrica 7
AU - Australia 5
CH - Svizzera 5
EC - Ecuador 5
IQ - Iraq 5
AT - Austria 4
CL - Cile 4
CO - Colombia 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
MA - Marocco 3
NP - Nepal 3
PH - Filippine 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PK - Pakistan 2
TW - Taiwan 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
VI - Stati Uniti Isole Vergini 1
Totale 13.832
Città #
Woodbridge 3.207
Wilmington 2.824
Houston 2.498
Fairfield 365
Singapore 345
Chandler 268
Ashburn 222
Ann Arbor 221
Seattle 138
San Jose 124
Jacksonville 117
Cambridge 116
Beijing 98
Kraków 85
Dublin 84
Rome 80
New York 75
Hong Kong 67
Medford 63
Dearborn 62
Santa Clara 57
Helsinki 53
Zhengzhou 47
Los Angeles 41
The Dalles 41
Council Bluffs 39
Milan 34
Ho Chi Minh City 29
Lawrence 29
Tokyo 24
Hanoi 23
Lauterbourg 23
Munich 22
São Paulo 22
Menlo Park 20
San Diego 18
San Francisco 16
Moscow 15
Boardman 14
Palo Alto 14
Redondo Beach 13
Shanghai 13
Chicago 12
Mülheim 12
Phoenix 12
Warsaw 12
Brussels 11
Buffalo 11
Nanjing 11
Orem 11
London 10
Montreal 10
Verona 10
Dallas 9
Stockholm 9
Creede 8
Falls Church 8
Jakarta 8
Brno 7
Denver 7
Nuremberg 7
Amsterdam 6
Ankara 6
Belo Horizonte 6
Boston 6
Columbus 6
Dong Ket 6
Hefei 6
Olomouc 6
Rio de Janeiro 6
Schiffdorf 6
Atlanta 5
Brooklyn 5
Charlotte 5
Johannesburg 5
Kunming 5
Manchester 5
Poplar 5
Redwood City 5
University Park 5
Chennai 4
Dhaka 4
Frankfurt am Main 4
Guangzhou 4
Madrid 4
Nanchang 4
Southport 4
Anápolis 3
Auburn Hills 3
Brasília 3
Chengdu 3
Colorado Springs 3
Curitiba 3
Honolulu 3
Jinan 3
Lausanne 3
Mountain View 3
Riyadh 3
Ahmedabad 2
Amman 2
Totale 12.021
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 577
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 508
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 489
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 486
Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. 486
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 486
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. 481
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 476
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 474
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. 469
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb 468
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 467
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 463
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 462
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. 461
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 458
Multidrug resistance after lamivudine therapy for chronic hepatitis B 456
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection 447
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 439
Aciclovir, herpes viruses and HIV: a never-ending story 430
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance 424
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 422
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. 401
Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. 395
Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen 393
Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon 393
Epidemiological burden estimates for pathologies with a non constant risk: an application to HCV in Italy according to age, Metavir score, and genotype 391
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 381
Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients 380
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection 361
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 301
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 102
Evaluation of the antibody response to EBNA-1 in EBV infections | VALIDITA DELLA RICERCA DEGLI ANTICORPI ANTI EBNA-1 NELLA DIAGNOSTICA DELLE INFEZIONI DA EBV 85
Therapy and prevention of infective endocarditis 42
Totale 13.954
Categoria #
all - tutte 29.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 0 19
2021/2022441 24 36 36 22 4 32 21 13 103 33 15 102
2022/2023608 54 65 54 92 41 118 35 54 51 7 25 12
2023/2024200 31 2 11 4 6 66 0 14 4 8 0 54
2024/2025795 24 170 95 44 48 30 61 34 121 61 55 52
2025/20261.383 97 57 137 156 128 53 276 127 161 97 68 26
Totale 13.954